Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment

NCT07431385 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Fidia Farmaceutici s.p.a.